INS and type 2 diabetes mellitus: Treatment of T2D also involves strategies aiming at stimulating insulin secretion from already metabolically stressed β-cells, i.e., using various secretagogues, which in many cases has been associated with a “treat-to-failure” scenario with accelerated β-cell stress and eventual loss of β-cell function17,18.